231 related articles for article (PubMed ID: 16249552)
1. Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan.
Wen CP; Cheng TY; Tsai SP; Hsu HL; Wang SL
Diabetes Care; 2005 Nov; 28(11):2756-61. PubMed ID: 16249552
[TBL] [Abstract][Full Text] [Related]
2. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
[TBL] [Abstract][Full Text] [Related]
3. High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study.
Rijkelijkhuizen JM; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD; Dekker JM
Diabetes Care; 2007 Feb; 30(2):332-6. PubMed ID: 17259503
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
5. BMI and All-Cause Mortality in Normoglycemia, Impaired Fasting Glucose, Newly Diagnosed Diabetes, and Prevalent Diabetes: A Cohort Study.
Lee EY; Lee YH; Yi SW; Shin SA; Yi JJ
Diabetes Care; 2017 Aug; 40(8):1026-1033. PubMed ID: 28400430
[TBL] [Abstract][Full Text] [Related]
6. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?
DECODE Study Group, European Diabetes Epidemiology Group
Diabetes Care; 2003 Mar; 26(3):688-96. PubMed ID: 12610023
[TBL] [Abstract][Full Text] [Related]
7. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.
DECODE Study Group, the European Diabetes Epidemiology Group.
Arch Intern Med; 2001 Feb; 161(3):397-405. PubMed ID: 11176766
[TBL] [Abstract][Full Text] [Related]
8. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
9. EPIDEMIOLOGY OF DIABETES AND IMPAIRED FASTING GLUCOSE IN A RURAL COMMUNITY OF NIGERIAN NIGER DELTA REGION.
Alikor CA; Emem-Chioma PC
Niger J Med; 2015; 24(2):114-24. PubMed ID: 26353421
[TBL] [Abstract][Full Text] [Related]
10. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
[TBL] [Abstract][Full Text] [Related]
11. Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years.
Chen KT; Chen CJ; Gregg EW; Imperatore G; Narayan KM
Diabetes Res Clin Pract; 2003 Jun; 60(3):177-82. PubMed ID: 12757990
[TBL] [Abstract][Full Text] [Related]
12. Fasting blood glucose at admission and survival in patients with dilated cardiomyopathy: a single-center cohort study.
Li X; Jiang R; Kong H; Shu Y; Li Q; Hua W
Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):457-62. PubMed ID: 24918531
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study.
Chung RH; Chuang SY; Chen YE; Li GH; Hsieh CH; Chiou HY; Hsiung CA
BMJ Open Diabetes Res Care; 2023 Jun; 11(3):. PubMed ID: 37328274
[TBL] [Abstract][Full Text] [Related]
14. Effects of isolated post-challenge hyperglycemia on mortality in American Indians: the Strong Heart Study.
Lu W; Resnick HE; Jain AK; Adams-Campbell LL; Jablonski KA; Gottlieb AM; Robbins DC; Howard BV
Ann Epidemiol; 2003 Mar; 13(3):182-8. PubMed ID: 12604162
[TBL] [Abstract][Full Text] [Related]
15. [Influence of impaired fasting glucose on the incidence and prognosis of atherosclerosis in various vascular regions].
Espinola-Klein C; Rupprecht HJ; Blankenberg S; Bickel C; Fossmeyer U; Kopp H; Victor A; Peetz D; Lackner K
Z Kardiol; 2004; 93 Suppl 4():IV48-55. PubMed ID: 15085366
[TBL] [Abstract][Full Text] [Related]
16. Metabolic risk factors in southern Taiwanese with impaired fasting glucose of 100 to 109 mg/dL.
Hung WW; Chang CJ; Lee YJ; Hsin SC; Lin KD; Hsieh MC; Hsiao PJ; Shin SJ
Metabolism; 2007 Apr; 56(4):528-32. PubMed ID: 17379012
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin.
Nakagami T;
Diabetologia; 2004 Mar; 47(3):385-394. PubMed ID: 14985967
[TBL] [Abstract][Full Text] [Related]
18. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
[TBL] [Abstract][Full Text] [Related]
19. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
Tominaga M; Eguchi H; Manaka H; Igarashi K; Kato T; Sekikawa A
Diabetes Care; 1999 Jun; 22(6):920-4. PubMed ID: 10372242
[TBL] [Abstract][Full Text] [Related]
20. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.
Wei M; Gaskill SP; Haffner SM; Stern MP
Diabetes Care; 1998 Jul; 21(7):1167-72. PubMed ID: 9653614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
